A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

Clinical trial NCT03219268 · COMPLETED

Trial details

NCT number: NCT03219268
Sponsor: MacroGenics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Hematologic Neoplasms Ovarian Cancer HER2-positive Advanced Solid Tumors Non Small Cell Lung Cancer Small-cell Lung Cancer Squamous Cell Carcinoma of Head and Neck Cholangiocarcinoma Cervical Cancer TNBC - Triple-Negative Breast Cancer

Start date: 2017-08-18
Primary completion: 2023-02-08
Enrollment: 277

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.